申请人:Cooper Alan B.
公开号:US20090118284A1
公开(公告)日:2009-05-07
Disclosed are the ERK inhibitors of formula 1.0:
and the pharmaceutically acceptable salts, esters and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
本发明公开了式1.0的ERK抑制剂及其药学上可接受的盐、酯和溶剂化物。其中,Q是一个带有桥或融合环的哌啶或哌嗪环。哌啶环中可以在环上具有双键。所有其他取代基如本文所定义。本发明还公开了使用式1.0的化合物治疗癌症的方法。